14 August 2013 in PLOS ONE
To compare the effects of transcatheter arterial chemoembolization (TACE) with transcatheter arterial embolization (TAE) on liver function, hepatic damage, and hepatic fibrogenesis in a rabbit tumor model. Thirty-nine New Zealand white rabbits implanted with VX2 tumors in the left liver lobes were randomly divided into three groups: TAE, TACE, and control group. In the TAE group (n = 15), polyvinyl alcohol particles (PVAs) were used for left hepatic artery embolization. In the TACE group (n = 15), the tumors were treated with left hepatic arterial infusions of a suspension of 10-hydroxycamptothecin and lipiodol, followed by embolization with PVAs. In the control group (n = 9), the animals received sham treatment with distilled water. Serum and liver samples were collected at 6 hours, 3 days and 7 days after treatment. Liver damage was measured using a liver function test and histological analyses. Liver fibrogenesis and hepatic stellate cell (HSC) activation were evaluated using Sirius Red and anti-alpha-smooth muscle actin (α-SMA) immunohistochemical stains. TACE caused liver injury with greater increases in serum alanine aminotransferase and aspartate aminotransferase levels on day 3 (P<0.05). Histological analyses revealed increased hepatic necrosis in adjacent non-tumorous liver tissue from day 3 compared to the TAE group (Suzuki score of 2.33±1.29 versus 1.13±1.18, P = 0.001). HSC activation and proliferation were significantly increased in the TACE group compared to the control group at 3 and 7 days after treatment (0.074±0.014 vs. 0.010±0.006, and 0.088±0.023 vs. 0.017±0.009, P<0.05). Sirius Red staining demonstrated a statistically significant increase in collagen deposition in the livers in the TACE group 7 days after embolization compared to the control group (0.118±0.012 vs. 0.060±0.017, P = 0.05). The results of this animal study revealed that TACE induced prominent hepatocellular damage and hepatic fibrogenesis, which compromised liver function and may be responsible for chronic liver decompensation.
1 February 2020 in Veterinary Record Case Reports
A congenital extrahepatic porto‐internal thoracic shunt was attenuated with cellophane banding in a cat with multiple embryogenetic anomalies. Changes in the postoperative shunt diameter were monitored using ultrasound and CT angiography. The patient improved clinically after cellophane banding, showing resolution of hepatic encephalopathy, weight gain and normalisation of serum ammonia and bile acid levels. The shunt vessel stopped narrowing at four postoperative weeks, and a complete closure was surgically achieved after 9 months. The patient stopped vomiting immediately after the second surgery. Additional histopathological results suggested lymphoplasmacytic enteritis, which was treated medically. The reason why complete closure with the cellophane banding was not attained remains unclear. However, it can be hypothesised that the material did not function as normal cellophanes or that placement of the cellophane within the falciform ligament did not result in the usual inflammatory reaction or closure of the vessel.